Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mari Iida

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Molecular Cancer|December 30, 2025
Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapyMari Iida, Toni M Brand, Megan M Starr, et al.
Cancer Treatment and Research|August 23, 2025
Immunotherapy in Head and Neck CancerBridget E Crossman, Regan L Harmon, Mari Iida, et al.
BMC Cancer|April 24, 2022
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancerMari Iida, Nellie K McDaniel, Kourtney L Kostecki, et al.
BMC Cancer|October 11, 2012
Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neckHanneke Stegeman, Johannes H Kaanders, Deric L Wheeler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2010
Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptorsTim J Kruser, Deric L Wheeler, Eric A Armstrong, et al.
Molecular Cancer Therapeutics|April 3, 2019
Correction: Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-negative Breast CancerToni M Brand, Mari Iida, Emily F Dunn, et al.
Molecular Cancer Therapeutics|March 18, 2014
Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancerToni M Brand, Mari Iida, Emily F Dunn, et al.
Cancer Research|August 20, 2014
AXL mediates resistance to cetuximab therapyToni M Brand, Mari Iida, Andrew P Stein, et al.
Scientific Reports|May 28, 2026
Inhibition of autophagy increases head and neck cancer sensitivity to cetuximab and radiation therapyYong-Syu Lee, Kwangok P Nickel, Samantha T Bradley, et al.
Science Signaling|January 5, 2017
RETRACTED: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptorToni M Brand, Mari Iida, Kelsey L Corrigan, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Molecular Cancer|December 30, 2025
Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapyMari Iida, Toni M Brand, Megan M Starr, et al.
Cancer Treatment and Research|August 23, 2025
Immunotherapy in Head and Neck CancerBridget E Crossman, Regan L Harmon, Mari Iida, et al.
BMC Cancer|April 24, 2022
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancerMari Iida, Nellie K McDaniel, Kourtney L Kostecki, et al.
BMC Cancer|October 11, 2012
Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neckHanneke Stegeman, Johannes H Kaanders, Deric L Wheeler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2010
Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptorsTim J Kruser, Deric L Wheeler, Eric A Armstrong, et al.
Molecular Cancer Therapeutics|April 3, 2019
Correction: Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-negative Breast CancerToni M Brand, Mari Iida, Emily F Dunn, et al.
Molecular Cancer Therapeutics|March 18, 2014
Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancerToni M Brand, Mari Iida, Emily F Dunn, et al.
Cancer Research|August 20, 2014
AXL mediates resistance to cetuximab therapyToni M Brand, Mari Iida, Andrew P Stein, et al.
Scientific Reports|May 28, 2026
Inhibition of autophagy increases head and neck cancer sensitivity to cetuximab and radiation therapyYong-Syu Lee, Kwangok P Nickel, Samantha T Bradley, et al.
Science Signaling|January 5, 2017
RETRACTED: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptorToni M Brand, Mari Iida, Kelsey L Corrigan, et al.
Pageof 6